165 related articles for article (PubMed ID: 37036052)
1. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A; Del Bello F; Giorgioni G; Piergentili A; Saab E; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Quaglia W
Med Res Rev; 2023 Sep; 43(5):1607-1667. PubMed ID: 37036052
[TBL] [Abstract][Full Text] [Related]
2. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
3. Orexins/hypocretins: pain regulation and cellular actions.
Chiou LC; Lee HJ; Ho YC; Chen SP; Liao YY; Ma CH; Fan PC; Fuh JL; Wang SJ
Curr Pharm Des; 2010; 16(28):3089-100. PubMed ID: 20687883
[TBL] [Abstract][Full Text] [Related]
4. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
5. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.
Ziolkowska A; Spinazzi R; Albertin G; Nowak M; Malendowicz LK; Tortorella C; Nussdorfer GG
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):423-9. PubMed ID: 16157481
[TBL] [Abstract][Full Text] [Related]
6. Orexin receptors: pharmacology and therapeutic opportunities.
Scammell TE; Winrow CJ
Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides and neuropeptide receptors: drug targets, and peptide and non-peptide ligands: a tribute to Prof. Dieter Seebach.
Hoyer D; Bartfai T
Chem Biodivers; 2012 Nov; 9(11):2367-87. PubMed ID: 23161624
[TBL] [Abstract][Full Text] [Related]
8. Selective orexin receptor antagonists.
Lebold TP; Bonaventure P; Shireman BT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
[TBL] [Abstract][Full Text] [Related]
9. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
10. Expression of orexin B and its receptor 2 in rat testis.
Liguori G; Pavone LM; Assisi L; Langella E; Tafuri S; Mirabella N; Costagliola A; Vittoria A
Gen Comp Endocrinol; 2017 Feb; 242():66-73. PubMed ID: 26631456
[TBL] [Abstract][Full Text] [Related]
11. Preproorexin and orexin receptors are expressed in cortisol-secreting adrenocortical adenomas, and orexins stimulate in vitro cortisol secretion and growth of tumor cells.
Spinazzi R; Rucinski M; Neri G; Malendowicz LK; Nussdorfer GG
J Clin Endocrinol Metab; 2005 Jun; 90(6):3544-9. PubMed ID: 15797953
[TBL] [Abstract][Full Text] [Related]
12. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
13. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.
Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM
Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369
[TBL] [Abstract][Full Text] [Related]
14. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.
Heifetz A; Barker O; Morris GB; Law RJ; Slack M; Biggin PC
Biochemistry; 2013 Nov; 52(46):8246-60. PubMed ID: 24144388
[TBL] [Abstract][Full Text] [Related]
15. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
16. Orexin receptor subtype activation and locomotor behaviour in the rat.
Samson WK; Bagley SL; Ferguson AV; White MM
Acta Physiol (Oxf); 2010 Mar; 198(3):313-24. PubMed ID: 19889100
[TBL] [Abstract][Full Text] [Related]
17. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity.
Jones DN; Gartlon J; Parker F; Taylor SG; Routledge C; Hemmati P; Munton RP; Ashmeade TE; Hatcher JP; Johns A; Porter RA; Hagan JJ; Hunter AJ; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):210-8. PubMed ID: 11205421
[TBL] [Abstract][Full Text] [Related]
18. Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design.
Lessel U; Ferrara M; Heine N; Marelli C; Carrettoni L; Pfau R; Schmidt E; Riether D
J Chem Inf Model; 2021 Dec; 61(12):5893-5905. PubMed ID: 34817173
[TBL] [Abstract][Full Text] [Related]
19. Orexin 2 receptor is involved in orexin A-induced hyperlocomotion in rats.
Maehara S; Furukawa J; Ota T
Pharmacol Rep; 2019 Dec; 71(6):1147-1150. PubMed ID: 31655279
[TBL] [Abstract][Full Text] [Related]
20. Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal.
Silveyra P; Catalano PN; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E820-8. PubMed ID: 17122088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
